Archives
-
Tetrandrine N1798: Reliable Cell Assay Design
2026-09-05
Learn how Tetrandrine (SKU N1798) can be incorporated into cell viability, proliferation, and ion channel workflows while controlling solubility, vehicle, and interpretation risks. This scenario-based guide connects product specifications with practical assay design and evidence-aware data analysis.
-
Liproxstatin-1 Workflow for Ferroptosis Research
2026-09-04
Liproxstatin-1 is a nanomolar ferroptosis inhibitor for separating lipid peroxidation-driven death from apoptosis, oxidative stress, and copper-associated cytotoxicity. This practical guide covers cell-based rescue assays, GPX4-deficient cell protection, renal injury workflows, assay controls, and troubleshooting.
-
Coumestrol, PMAIP1, and Ferroptosis in RA
2026-09-04
A 2026 study identifies a PMAIP1-dependent ferroptosis mechanism through which Coumestrol suppresses rheumatoid arthritis fibroblast-like synoviocyte proliferation and inflammatory signaling. The work connects TRIM3-mediated protein stability, mitochondrial stress, and iron accumulation, while providing a useful in vitro framework for evaluating this compound beyond its established estrogen receptor pharmacology.
-
Ionomycin calcium salt: Calcium Signaling Workflows
2026-09-03
Ionomycin calcium salt provides a practical way to raise intracellular Ca2+ and connect calcium dynamics with secretion, protein regulation, viability, and apoptosis assays. This workflow-focused guide shows how to build controlled calcium perturbation experiments while using the malignant pleural mesothelioma literature to improve assay stratification without overstating translational evidence.
-
BMS-345541 Hydrochloride in Cell-Fate Research
2026-09-03
BMS-345541 hydrochloride is an allosteric IKK inhibitor that can separate NF-κB transcriptional survival signals from RIPK1-driven cell death. This article presents a pathway-aware framework for inflammation research, T-ALL apoptosis studies, and mechanistically resolved assay design.
-
Podophyllotoxin Derivative 5p and MDR
2026-09-02
The reference study shows that podophyllotoxin derivative 5p combines catalytic topoisomerase IIα inhibition with suppression of microtubule polymerization, producing activity against several multidrug-resistant cancer models. Its effects connect target inhibition with G2/M arrest, apoptosis, pyroptosis, reduced drug-efflux protein expression, and impaired resistant-tumor growth in xenografts.
-
Aztreonam for Reliable Cell and Microbial Assays
2026-09-02
Aztreonam (SKU A5931) supports mechanism-aware Gram-negative research while highlighting critical controls for cell viability, progenitor-cell, and hepatic enzyme studies. This scenario-driven guide covers interpretation, solution preparation, assay compatibility, and practical supplier selection.
-
Leucovorin Calcium in Antifolate Assays
2026-09-01
Leucovorin Calcium enables controlled methotrexate-rescue experiments in cell lines, organoids, and tumor–stroma assembloids. This workflow uses calcium folinate to separate folate-pathway protection from microenvironment-driven drug resistance, improving the interpretability of viability and proliferation data.
-
Triamcinolone B1859: In Vitro Workflow Guide
2026-09-01
Triamcinolone B1859 provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide explains preparation, assay controls, QC, and handling boundaries for research use; it is not intended for diagnostic, therapeutic, or clinical applications.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-31
The reference study developed chemically modified p21 mRNA packaged in lipid nanoparticles for localized intravesical treatment of bladder cancer. Its preclinical data connect restored nuclear p21 expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, and reduced tumor growth, while also highlighting delivery and manufacturing questions for future translation.
-
WAY-100635: A Causal Probe for Pain Circuits
2026-08-31
WAY-100635 enables precise serotonin receptor antagonist research by testing whether 5-HT1A signaling contributes to sensory, affective, and cognitive pain phenotypes. This article presents an assay-centered framework that extends cannabidiol findings without overstating serotonergic mechanism.
-
Açaí Extracts in Human Hepatocytes: Key Findings
2026-08-30
Raichura and colleagues evaluated consumer-relevant açaí extracts for hepatocyte cytotoxicity and modulation of drug-metabolizing enzymes and transporters. The study found extract-specific, dose- and time-dependent loss of viability but no significant induction of the tested CYP450 or transporter genes, highlighting why botanical-drug interaction studies must distinguish cellular toxicity from pathway activation.
-
MOG (35-55) Peptide: A Mechanistic EAE Guide
2026-08-29
Explore how the MOG (35-55) myelin oligodendrocyte glycoprotein peptide supports reproducible EAE and multiple sclerosis research. This guide connects antigen-driven disease modeling with the PARP7–STAT1/STAT2 pathway and translates that insight into practical assay decisions.
-
Neurospora EGO-like Complex Regulates TOR Signaling
2026-08-28
The reference study defines how the VTA–GTR2 EGO-like system controls nutrient-responsive TORC1 activity and localization in Neurospora crassa. Its findings distinguish amino acid sensing from glucose-dependent regulation and connect vacuolar positioning of TORC1 with a possible mechanism linking metabolism to circadian rhythmicity.
-
ATP Solution (100 mM): Reliable Assay Workflows
2026-08-28
Learn how ATP Solution (100 mM), SKU K1043, supports controlled kinase, transcription, ligation, and phosphorylation workflows that influence cell-proliferation and cytotoxicity research. This scenario-based guide covers compatibility, optimization, interpretation, storage, and practical vendor selection.